Safety and efficacy of switching to biosimilars in IBD

被引：0
|
作者：
Isobel Leake
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2016年 / 13卷 / 6期
关键词：
D O I：
10.1038/nrgastro.2016.79
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：314 / 314
相关论文
共 50 条
  • [31] Biosimilars and safety issues
    Dammacco, Franco
    Abbracchio, Maria Pia
    Gesualdo, Loreto
    Goffredo, Franca
    Ronco, Claudio
    Zanella, Alberto
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 656 - 658
  • [32] Vedolizumab Efficacy and Safety in a Tertiary Care IBD Clinical Practice
    Vivio, Emily
    Kanuri, Navya D.
    Dey, Neelendu
    Chen, Chien-Huan
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    GASTROENTEROLOGY, 2015, 148 (04) : S871 - S872
  • [33] Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
    Dudek, Patrycja
    Fabisiak, Adam
    Zatorski, Hubert
    Malecka-Wojciesko, Ewa
    Talar-Wojnarowska, Renata
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [34] Efficacy and safety of two bowel preparations for colonoscopy in IBD patients
    Frankovic, I.
    Martinato, M.
    Mescoli, C.
    Caccaro, R.
    Frigo, A. C.
    Rugge, M.
    Sturniolo, G. C.
    D'Inca, R.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S278 - S279
  • [35] Biologicals and biosimilars in IBD-the road to personalized treatment
    Gecse, Krisztina B.
    Lakatos, Peter L.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (02) : 74 - 76
  • [36] Efficacy and safety of infliximab biosimilars in the treatment of patients with moderate-to-severe psoriasis
    Chasapi, Vasiliki
    Routsi, Eleni
    Lantzou, Sotiria
    Papoutsaki, Marina
    Panagakis, Pantelis
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [37] Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologic
    de Mora, Fernando
    Fauser, Bart C. J. M.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2017, 35 (01) : 81 - 86
  • [38] Biosimilars in IBD: What Every Clinician Needs to Know
    Angyal A.
    Bhat S.
    Current Gastroenterology Reports, 2024, 26 (3) : 77 - 85
  • [39] Erratum to: Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
    Howard Lee
    The AAPS Journal, 2015, 17 : 1520 - 1521
  • [40] IBD Indication extrapolation for anti-TNF biosimilars
    Casteele, Niels Vande
    Sandborn, William J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (07) : 373 - 374
12345